--- title: "CanSino Biologics Inc. nimmt am World Governments Summit 2026 in Dubai teil" type: "News" locale: "en" url: "https://longbridge.com/en/news/274972790.md" description: "CanSino Biologics Inc. participated as the only invited vaccine company at the World Governments Summit 2026 in Dubai. CEO Dr. Xuefeng Yu and CCO Jeanne Wang represented the company, engaging with international political leaders and partners. The company highlighted its innovation and commitment to expanding access to modern vaccines globally." datetime: "2026-02-05T12:33:05.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/274972790.md) - [en](https://longbridge.com/en/news/274972790.md) - [zh-HK](https://longbridge.com/zh-HK/news/274972790.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/274972790.md) | [繁體中文](https://longbridge.com/zh-HK/news/274972790.md) # CanSino Biologics Inc. nimmt am World Governments Summit 2026 in Dubai teil CanSino Biologics Inc. hat als einziges weltweit eingeladenes Impfstoffunternehmen an der World Governments Summit 2026 in Dubai teilgenommen. Vorstandsvorsitzender Dr. Xuefeng Yu und Chief Commercial Officer Jeanne Wang vertraten das Unternehmen und führten Gespräche mit internationalen politischen Entscheidungsträgern und Partnern. Das Unternehmen betonte seine Innovationskraft und das Engagement, den Zugang zu modernen Impfstoffen weltweit zu erweitern. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cansino Biologics Inc. published the original content used to generate this news brief on February 05, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here ### Related Stocks - [CanSinoBIO (688185.CN)](https://longbridge.com/en/quote/688185.CN.md) - [CANSINOBIO (06185.HK)](https://longbridge.com/en/quote/06185.HK.md) ## Related News & Research - [CanSino Biologics Wins PIC/S GMP Nod for Key Conjugate Vaccines](https://longbridge.com/en/news/277909067.md) - [CanSinoBIO Showcases Vaccine Innovation at World Government Summit 2026](https://longbridge.com/en/news/275321399.md) - [CanSino Biologics forecasts significant non-recurring profit for 2025](https://longbridge.com/en/news/273811975.md) - [Sino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 billion](https://longbridge.com/en/news/277695972.md) - [Az cancels adjourned 2026 special meeting after quorum shortfall](https://longbridge.com/en/news/277990639.md)